Dec 01, 2017 12:30 pm UTC| Business
NEW YORK, Dec. 01, 2017 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Legg Mason,...
Dec 01, 2017 12:30 pm UTC| Business
NEW YORK, Dec. 01, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FS Investment...
Dec 01, 2017 12:29 pm UTC| Business
LAS VEGAS, Dec. 01, 2017 -- A research study titled, “Hybrid Power Solutions Market by System Type, Power Rating and End User - Global Industry Analysis and Forecast to 2023” published by Crystal Market Research, states...
Dec 01, 2017 12:06 pm UTC| Business
Dublin, Dec. 01, 2017 -- The "Diabetic Foot Ulcer Therapeutics - Pipeline Analysis 2017" report has been added to Research and Markets' offering. The study analysed that the diabetic foot ulcer pipeline...
Dec 01, 2017 12:02 pm UTC| Business
Dublin, Dec. 01, 2017 -- The "Cyclin-Dependent Kinase (CDK) Inhibitors Therapeutics - Pipeline Analysis 2017" report has been added to Research and Markets' offering. The study analyzed that the CDK...
Dec 01, 2017 12:02 pm UTC| Business
Dublin, Dec. 01, 2017 -- The "Global Smart Tracker Market 2017-2021" report has been added to Research and Markets' offering. The global smart tracker market to grow at a CAGR of 9.22% during the...
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
Dec 01, 2017 12:01 pm UTC| Business
PRESS RELEASE Active Biotech (Nasdaq Stockholm: ACTI) today announced initial results from the Phase II proof of concept study of laquinimod in Primary Progressive MS (PPMS) sponsored by Active Biotech's partner...
FxWirePro- Major Economic Events for the day